Vectura investors ignore critics and back tobacco giant takeoverTobacco giant Philip Morris International (PMI) has won the shareholder vote it needed for its controversial £1.1 billion Share XVectura investors ignore critics and back tobacco giant takeoverhttps://pharmaphorum.com/news/vectura-investors-ignore-critics-and-back-tobacco-giant-takeover/
EU ‘negotiating with Valneva’ over COVID-19 vaccine contractThe European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to Share XEU ‘negotiating with Valneva’ over COVID-19 vaccine contracthttps://pharmaphorum.com/news/eu-negotiating-with-valneva-over-covid-19-vaccine-contract/
Valneva slumps as UK dumps €1.4bn order for COVID-19 jabThe UK has terminated its order for up to 190 million doses of a COVID-19 vaccine developed by Share XValneva slumps as UK dumps €1.4bn order for COVID-19 jabhttps://pharmaphorum.com/news/valneva-slumps-as-uk-dumps-e1-4bn-order-for-covid-19-jab/
The benefits of being a family-run pharma companyThe third generation of his family to hold a leadership role at Chiesi Group, Giacomo Chiesi reflects on Share XThe benefits of being a family-run pharma companyhttps://pharmaphorum.com/sales-marketing/chiesi-family-run-pharma-company-benefits/
The post-COVID future of physician sample access and engagementBuilding modern commercialisation strategies requires pharma to find the right balance of old ways and new approaches, says Share XThe post-COVID future of physician sample access and engagementhttps://pharmaphorum.com/sales-marketing/covid-physician-pharma-access-engagement/
EFPIA: Partnership is the key to healthcare’s biggest challengesThe European pharma body’s new Health Collaboration Guide hopes to inspire greater partnership working across healthcare, showcasing award-winning Share XEFPIA: Partnership is the key to healthcare’s biggest challengeshttps://pharmaphorum.com/sales-marketing/efpia-pharma-healthcare-partnership-guide/
How to optimise pharma’s digital HCP engagementPharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if Share XHow to optimise pharma’s digital HCP engagementhttps://pharmaphorum.com/debates-insight-sales-marketing/how-to-optimise-pharmas-digital-hcp-engagement/
Ensuring delivery of healthcare professional educationPharma companies always need to know they can get the right information to the right people at the Share XEnsuring delivery of healthcare professional educationhttps://pharmaphorum.com/debates-insight-sales-marketing/ensuring-delivery-of-healthcare-professional-education/
Good data supports pharma sales reps to drive lead generationAllow pharma sales reps to focus on the job in hand by making sure they have access to Share XGood data supports pharma sales reps to drive lead generationhttps://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/
Identifying KOLs in Growing and Emerging MarketsThe process of discovering HCPs who are leading key opinion leaders (KOLs) in emerging and growing markets is Share XIdentifying KOLs in Growing and Emerging Marketshttps://pharmaphorum.com/partner-content/identifying-kols-in-growing-and-emerging-markets/
Pathway To Effective Stakeholder MappingBefore developing any stakeholder engagement plan, it is crucial to have a clear understanding of all the relevant Share XPathway To Effective Stakeholder Mappinghttps://pharmaphorum.com/partner-content/pathway-to-effective-stakeholder-mapping/
American Conference Institute’s Premiere Conference on Life Sciences AntitrustAntitrust Priorities Under a New Enforcement Regime Share XAmerican Conference Institute’s Premiere Conference on Life Sciences Antitrusthttps://pharmaphorum.com/events/american-conference-institutes-premiere-conference-on-life-sciences-antitrust/
